{"DataElement":{"publicId":"6862466","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grading System Disease Response Grade","preferredDefinition":"The histologic grade of follicular lymphoma based on the 2008 World Health Organization classification.","longName":"WHO_FOLL_LYMP_GRADE","context":"DCI","contextVersion":"1","DataElementConcept":{"publicId":"6862465","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grading System Disease Response","preferredDefinition":"A grading system for follicular lymphoma based on the average number of large transformed cells in 10 neoplastic follicles at 40x high-power field._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","longName":"6862463v1.0:2459437v1.0","context":"DCI","contextVersion":"1","ObjectClass":{"publicId":"6862463","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grading System","preferredDefinition":"A grading system for follicular lymphoma based on the average number of large transformed cells in 10 neoplastic follicles at 40x high-power field.","longName":"C162997","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Follicular Lymphoma Histologic Grading System","conceptCode":"C162997","definition":"A grading system for follicular lymphoma based on the average number of large transformed cells in 10 neoplastic follicles at 40x high-power field.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-6351-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2459437","version":"1","preferredName":"Response","preferredDefinition":"In medicine, an improvement related to treatment.","longName":"C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F0AEBD7-964A-60D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-15","modifiedBy":"ONEDATA","dateModified":"2006-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-635F-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"HARTLEYG","dateModified":"2019-08-23","changeDescription":"Curated to support Protocol HEME_REMD477_102920","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6862457","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grading System Grade","preferredDefinition":"A position on a scale of intensity or amount or quality.","longName":"6862457v1.0","context":"DCI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Grade 3b","valueDescription":"WHO Follicular Lymphoma Histologic Grade 3b","ValueMeaning":{"publicId":"6862458","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grade 3b","longName":"6862458","preferredDefinition":"Solid sheets of centroblasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Follicular Lymphoma Histologic Grade 3b","conceptCode":"C163002","definition":"Solid sheets of centroblasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-6295-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90CBD492-62AE-4BDC-E053-F662850ABE4D","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","deletedIndicator":"No"},{"value":"Grade 3a","valueDescription":"WHO Follicular Lymphoma Histologic Grade 3a","ValueMeaning":{"publicId":"6862459","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grade 3a","longName":"6862459","preferredDefinition":"Centrocytes present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Follicular Lymphoma Histologic Grade 3a","conceptCode":"C163001","definition":"Centrocytes present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-62BA-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90CBD492-62D3-4BDC-E053-F662850ABE4D","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","deletedIndicator":"No"},{"value":"Grade 3","valueDescription":"WHO Follicular Lymphoma Histologic Grade 3","ValueMeaning":{"publicId":"6862460","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grade 3","longName":"6862460","preferredDefinition":"Greater than 15 centroblasts per high power field.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Follicular Lymphoma Histologic Grade 3","conceptCode":"C163000","definition":"Greater than 15 centroblasts per high power field.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-62DF-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90CBD492-62F8-4BDC-E053-F662850ABE4D","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","deletedIndicator":"No"},{"value":"Grade 2","valueDescription":"WHO Follicular Lymphoma Histologic Grade 2","ValueMeaning":{"publicId":"6862461","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grade 2","longName":"6862461","preferredDefinition":"6-15 centroblasts per high power field.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Follicular Lymphoma Histologic Grade 2","conceptCode":"C162999","definition":"6-15 centroblasts per high power field.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-6304-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90CBD492-631D-4BDC-E053-F662850ABE4D","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","deletedIndicator":"No"},{"value":"Grade 1","valueDescription":"WHO Follicular Lymphoma Histologic Grade 1","ValueMeaning":{"publicId":"6862462","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grade 1","longName":"6862462","preferredDefinition":"0-5 centroblasts per high power field.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Follicular Lymphoma Histologic Grade 1","conceptCode":"C162998","definition":"0-5 centroblasts per high power field.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-6329-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90CBD492-6342-4BDC-E053-F662850ABE4D","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"ONEDATA","dateModified":"2019-08-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2453188","version":"1","preferredName":"Grade","preferredDefinition":"A position on a scale of intensity or amount or quality.","longName":"C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0DDD1E7C-BBFA-66D1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-627C-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"HARTLEYG","dateModified":"2019-08-23","changeDescription":"Curated to support Protocol HEME_REMD477_102920","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor grade","type":"Preferred Question Text","description":"Tumor grade","url":null,"context":"DCI"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-6375-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"HARTLEYG","dateModified":"2019-08-23","changeDescription":"Curated to support Protocol HEME_REMD477_102920","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}